Daniel Rankin — Management

Get alerts when Daniel Rankin trades

Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: Swedish Orphan Biovitrum AB (publ).

12-month summary

Net seller over the last 12 months

3 open-market buys, 5 sales, 1 share award · SEK 12,697,446.39 bought, SEK 26,820,596.79 sold

Roles

28.10.2025 – 12.06.2026

Transactions (including via associated entities)

DateIssuerTransaction typeVolumePriceValueSource
12.06.2026✎Swedish Orphan Biovitrum AB (publ) Stockholm
SoldDisposal
9,529SEK 430.96
SEK 4,106,659.80
↗
12.06.2026Swedish Orphan Biovitrum AB (publ) Stockholm
Share award
15,367—
Share award
15,367 shares
↗
28.10.2025Swedish Orphan Biovitrum AB (publ) Stockholm
Bought — open marketAcquisition
15,000SEK 208.11
SEK 3,121,650.00
↗
28.10.2025Swedish Orphan Biovitrum AB (publ) Stockholm
SoldDisposal
15,000SEK 325.44
SEK 4,881,667.40
↗
28.10.2025Swedish Orphan Biovitrum AB (publ) Stockholm
Bought — open marketAcquisition
41,449SEK 208.11
SEK 8,625,951.39
↗
28.10.2025Swedish Orphan Biovitrum AB (publ) Stockholm
Bought — open marketAcquisition
6,500SEK 146.13
SEK 949,845.00
↗
28.10.2025Swedish Orphan Biovitrum AB (publ) Stockholm
SoldDisposal
41,449SEK 325.00
SEK 13,470,925.00
↗
28.10.2025Swedish Orphan Biovitrum AB (publ) Stockholm
SoldDisposal
6,500SEK 325.00
SEK 2,112,500.00
↗
28.10.2025Swedish Orphan Biovitrum AB (publ) Stockholm
SoldDisposal
6,971SEK 322.60
SEK 2,248,844.60
↗